Home › Focal Segmental Glomerulosclerosis › Virginia
Focal Segmental Glomerulosclerosis clinical trials in Virginia
3 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in Virginia.
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #26, Roanoke
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Virginia Nephrology, Arlington
- Nephrology Associates of Northern Virginia, Fairfax
- Virginia Commonwealth University, Richmond
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 30, 2026 · NCT07220083Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Children's Hospital of Richmond at VCU, Richmond
Recruiting
Up to age 75 · All sexes · Updated Aug 28, 2026 · NCT04065438From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.